CR
Christine Ring (Chief Legal Officer) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Nurix Therapeutics, Inc. (NRIX). The largest single filing was $642K of NRIX (37,600 sh × $17.07, as filed), executed Nov 24 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.8M
shares × price, as filed
Last traded
Nov 3
Filed Nov 4
Median ADV $54.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
13 filings
Sector per market data · by filing · past 12 months
Most traded names
NRIXRecent filings
NRIXSALE
Nurix Therapeutics, Inc.
View filing →
$138K8,148 sh × $16.96
Exec May 4
Filed May 4 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $124K
8,148 sh × $15.24
Exec Apr 2
Filed Apr 2 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $126K
8,148 sh × $15.44
Exec Mar 2
Filed Mar 2 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $238K
14,261 sh × $16.66
Exec Feb 9
Filed Feb 9 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $642K
37,600 sh × $17.07
Exec Nov 24 2025
Filed Nov 24 2025 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $113K
5,660 sh × $19.94
Exec Jan 31 2025
Filed Feb 3 2025 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $112K
5,760 sh × $19.50
Exec Jan 2 2025
Filed Jan 2 2025 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $125K
5,760 sh × $21.73
Exec Dec 2 2024
Filed Dec 2 2024 · 5:30 PM ET More filings →